Department of Organic Chemistry, Biochemistry and Catalysis, Faculty of Chemistry, University of Bucharest, Soseaua Panduri, 030018 Bucharest, Romania.
Molecules. 2021 Oct 4;26(19):6022. doi: 10.3390/molecules26196022.
Antimicrobial resistance was one of the top priorities for global public health before the start of the 2019 coronavirus pandemic (COVID-19). Moreover, in this changing medical landscape due to COVID-19, finding new organic structures with antimicrobial and antiviral properties is a priority in current research. The Biginelli synthesis that mediates the production of pyrimidine compounds has been intensively studied in recent decades, especially due to the therapeutic properties of the resulting compounds, such as calcium channel blockers, anticancer, antiviral, antimicrobial, anti-inflammatory or antioxidant compounds. In this review we aim to review the Biginelli syntheses reported recently in the literature that mediates the synthesis of antimicrobial compounds, the spectrum of their medicinal properties, and the structure-activity relationship in the studied compounds.
在 2019 年冠状病毒病(COVID-19)大流行之前,抗生素耐药性是全球公共卫生的首要重点之一。此外,由于 COVID-19,在这个不断变化的医疗环境中,寻找具有抗菌和抗病毒特性的新有机结构是当前研究的重点。介导嘧啶化合物生产的Biginelli 合成在最近几十年得到了深入研究,特别是由于所得到的化合物具有治疗特性,如钙通道阻滞剂、抗癌、抗病毒、抗菌、抗炎或抗氧化化合物。在这篇综述中,我们旨在回顾最近文献中报道的介导抗菌化合物合成的 Biginelli 合成、它们的药用特性谱以及研究化合物中的构效关系。